BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jones EA, Bergasa NV. The pruritus of cholestasis and the opioid system. JAMA 1992;268:3359-62. [PMID: 1333541 [PMID: 1333541 DOI: 10.1001/jama.1992.03490230089034] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Kambia NK, Dine T, Odou P, Bah S, Azar R, Gressier B, Dupin-spriet T, Luyckx M, Brunet C. Pharmacokinetics and dialysability of naltrexone in patients undergoing hemodialysis. European Journal of Drug Metabolism and Pharmacokinetics 2004;29:225-30. [DOI: 10.1007/bf03190603] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Shaw RJ, Dayal S, Good J, Bruckner AL, Joshi SV. Psychiatric Medications for the Treatment of Pruritus. Psychosomatic Medicine 2007;69:970-8. [DOI: 10.1097/psy.0b013e3181572799] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Grossmann M, Abiose A, Tangphao O, Blaschke TF, Hoffman BB. Morphine-induced venodilation in humans*. Clin Pharmacol Ther 1996;60:554-60. [DOI: 10.1016/s0009-9236(96)90151-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
4 Peer G, Kivity S, Agami O, Fireman E, Silverberg D, Blum M, Iaina A. Randomised crossover trial of naltrexone in uraemic pruritus. The Lancet 1996;348:1552-4. [DOI: 10.1016/s0140-6736(96)04176-1] [Cited by in Crossref: 189] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
5 Bergasa NV, Jones EA. THE PRURITUS OF CHOLESTASIS. Clinics in Liver Disease 1998;2:391-405. [DOI: 10.1016/s1089-3261(05)70014-3] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
6 Cies JJ, Giamalis JN. Treatment of cholestatic pruritus in children. American Journal of Health-System Pharmacy 2007;64:1157-62. [DOI: 10.2146/ajhp060453] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
7 Gabriel GM, Crone CC. Nocturnal pruritus in a cardiac pretransplant patient. Psychosomatics 2001;42:344-6. [PMID: 11496024 DOI: 10.1176/appi.psy.42.4.344] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
8 Thomas DA, Hammond DL. Microinjection of morphine into the rat medullary dorsal horn produces a dose-dependent increase in facial scratching. Brain Research 1995;695:267-70. [DOI: 10.1016/0006-8993(95)00871-m] [Cited by in Crossref: 40] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
9 Terra SG, Tsunoda SM. Opioid antagonists in the treatment of pruritus from cholestatic liver disease. Ann Pharmacother 1998;32:1228-30. [PMID: 9825091 DOI: 10.1345/aph.18115] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
10 Whitington PF. CHRONIC CHOLESTASIS OF INFANCY. Pediatric Clinics of North America 1996;43:1-26. [DOI: 10.1016/s0031-3955(05)70395-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
11 Mcloughlin M, Enns R. Endoscopy in the management of primary sclerosing cholangitis. Curr Gastroenterol Rep 2008;10:177-85. [DOI: 10.1007/s11894-008-0040-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
12 Ajayi AA, Kolawole BA, Udoh SJ. Endogenous opioids, µ-opiate receptors and chloroquine-induced pruritus: A double-blind comparison of naltrexone and promethazine in patients with malaria fever who have an established history of generalized chloroquine-induced itching. International Journal of Dermatology 2004;43:972-7. [DOI: 10.1111/j.1365-4632.2004.02347.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
13 Fukuda K. Opioids. Miller's Anesthesia. Elsevier; 2010. pp. 769-824. [DOI: 10.1016/b978-0-443-06959-8.00027-3] [Cited by in Crossref: 17] [Article Influence: 1.4] [Reference Citation Analysis]
14 Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M. Neuronal Control of Skin Function: The Skin as a Neuroimmunoendocrine Organ. Physiological Reviews 2006;86:1309-79. [DOI: 10.1152/physrev.00026.2005] [Cited by in Crossref: 359] [Cited by in F6Publishing: 299] [Article Influence: 22.4] [Reference Citation Analysis]
15 Marinangeli F, Guetti C, Angeletti C, Bonetti C, Paladini A, Piroli A, Varrassi G. Intravenous naloxone plus transdermal buprenorphine in cancer pain associated with intractable cholestatic pruritus. J Pain Symptom Manage 2009;38:e5-8. [PMID: 19699606 DOI: 10.1016/j.jpainsymman.2009.05.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
16 Metze D, Reimann S, Luger T. Juckreiz — Symptom oder Krankheit. In: Plewig G, Przybilla B, editors. Fortschritte der praktischen Dermatologie und Venerologie. Berlin: Springer Berlin Heidelberg; 1997. pp. 77-86. [DOI: 10.1007/978-3-642-60534-5_13] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
17 Metze D, Reimann S, Luger TA. Effective Treatment of Pruritus with Naltrexone, an Orally Active Opiate Antagonist. Annals of the New York Academy of Sciences 1999;885:430-2. [DOI: 10.1111/j.1749-6632.1999.tb08705.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
18 Talwalkar JA, Lindor KD. Primary sclerosing cholangitis. Inflamm Bowel Dis. 2005;11:62-72. [PMID: 15674115 DOI: 10.1097/00054725-200501000-00009] [Cited by in Crossref: 86] [Cited by in F6Publishing: 68] [Article Influence: 5.1] [Reference Citation Analysis]
19 Bernstein JE. Opiate-mediated pruritus and citation etiquette. Journal of the American Academy of Dermatology 2000;43:324. [DOI: 10.1067/mjd.2000.107238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
20 Doria C. Effect of molecular adsorbent recirculating system in hepatitis C virus-related intractable pruritus. Liver Transplantation 2003;9:437-43. [DOI: 10.1053/jlts.2003.50055] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
21 Morgan, Lacey. Scratching and fasting: a study of pruritus and anorexia nervosa. British Journal of Dermatology 1999;140:453-6. [DOI: 10.1046/j.1365-2133.1999.02708.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
22 Roth LJ, Pugh EJ. The role of endoscopic biliary stents in palliative care. Palliat Med 1999;13:63-8. [DOI: 10.1191/026921699670064030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Swain MG, Vergalla J, Jones EA. Plasma endopeptidase 24.11 (enkephalinase) activity is markedly increased in cholestatic liver disease. Hepatology 1993;18:556-8. [DOI: 10.1002/hep.1840180312] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
24 Hunt CM, Washington K. Tetracycline-induced bile duct paucity and prolonged cholestasis. Gastroenterology 1994;107:1844-7. [PMID: 7958700 DOI: 10.1016/0016-5085(94)90830-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
25 Charlesworth EN, Beltrani VS. Pruritic dermatoses: overview of etiology and therapy. The American Journal of Medicine 2002;113:25-33. [DOI: 10.1016/s0002-9343(02)01434-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 3] [Article Influence: 2.1] [Reference Citation Analysis]
26 Bergasa NV. The pruritus of cholestasis. Semin Dermatol 1995;14:302-12. [PMID: 8679436 DOI: 10.1016/s1085-5629(05)80052-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
27 Schwartz IF, Iaina A. Management of uremic pruritus. Semin Dial 2000;13:177-80. [PMID: 10833778 DOI: 10.1046/j.1525-139x.2000.00050.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
28 Greaves MW. New Pathophysiological and Clinical Insights into Pruritus. The Journal of Dermatology 1993;20:735-40. [DOI: 10.1111/j.1346-8138.1993.tb01376.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
29 Phan NQ, Bernhard JD, Luger TA, Ständer S. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review. J Am Acad Dermatol. 2010;63:680-688. [PMID: 20462660 DOI: 10.1016/j.jaad.2009.08.052] [Cited by in Crossref: 109] [Cited by in F6Publishing: 77] [Article Influence: 9.1] [Reference Citation Analysis]
30 Bergasa NV, Schmitt JM, Talbot TL, Alling DW, Swain MG, Turner ML, Jenkins JB, Jones EA. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis. Hepatology. 1998;27:679-684. [PMID: 9500694 DOI: 10.1002/hep.510270307] [Cited by in Crossref: 127] [Cited by in F6Publishing: 102] [Article Influence: 5.3] [Reference Citation Analysis]
31 Jung SI, Seo CH, Jang K, Ham BJ, Choi IG, Kim JH, Lee BC. Efficacy of naltrexone in the treatment of chronic refractory itching in burn patients: preliminary report of an open trial. J Burn Care Res 2009;30:257-60; discussion 261. [PMID: 19165115 DOI: 10.1097/BCR.0b013e318198a282] [Cited by in Crossref: 20] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
32 Mansour-Ghanaei F, Taheri A, Froutan H, Ghofrani H, Nasiri-Toosi M, Bagherzadeh AH, Farahvash MJ, Mirmomen S, Ebrahimi-Dariani N, Farhangi E, Pourrasouli Z. Effect of oral naltrexone on pruritus in cholestatic patients. World J Gastroenterol 2006; 12(7): 1125-1128 [PMID: 16534857 DOI: 10.3748/wjg.v12.i7.1125] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
33 Metze D, Reimann S, Beissert S, Luger T. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. Journal of the American Academy of Dermatology 1999;41:533-9. [DOI: 10.1016/s0190-9622(99)80048-6] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
34 Kosmadakis G, Zerefos N. Uremic Pruritus. Int J Artif Organs 2006;29:938-43. [DOI: 10.1177/039139880602901003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
35 Oude Elferink R, Groen AK. Genetic defects in hepatobiliary transport. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2002;1586:129-45. [DOI: 10.1016/s0925-4439(01)00103-x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
36 Greaves M, Wall P. Pathophysiology of itching. The Lancet 1996;348:938-40. [DOI: 10.1016/s0140-6736(96)04328-0] [Cited by in Crossref: 137] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
37 Choi YS, Billings J. Opioid Antagonists. Journal of Pain and Symptom Management 2002;24:71-90. [DOI: 10.1016/s0885-3924(02)00424-4] [Cited by in Crossref: 105] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
38 Bergasa NV, Alling DW, Talbot TL, Wells MC, Jones E. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: A controlled study. Journal of the American Academy of Dermatology 1999;41:431-4. [DOI: 10.1016/s0190-9622(99)70117-9] [Cited by in Crossref: 117] [Cited by in F6Publishing: 12] [Article Influence: 5.1] [Reference Citation Analysis]
39 Wolf JL. Liver disease in pregnancy. Med Clin North Am 1996;80:1167-87. [PMID: 8804379 DOI: 10.1016/s0025-7125(05)70484-3] [Cited by in Crossref: 52] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Poupon R, Chazouillères O, Balkau B, Poupon RE. Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group. J Hepatol 1999;30:408-12. [PMID: 10190722 DOI: 10.1016/s0168-8278(99)80098-1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
41 Gurnani P, Miloh T, Chandar J, Landau DA, Hajjar F, Yosipovitch G. Systemic causes of non-dermatologic chronic pruritus in the pediatric population and their management: An unexplored area. Pediatr Dermatol 2021;38:1051-60. [PMID: 34515372 DOI: 10.1111/pde.14596] [Reference Citation Analysis]
42 Hägermark O, Wahlgren CF. Treatment of itch. Semin Dermatol 1995;14:320-5. [PMID: 8679439 DOI: 10.1016/s1085-5629(05)80055-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]